Bioceres Crop Solutions (BIOX) - 2021 Q4 - Earnings Call Presentation

Financial Performance - Annual revenue increased from $38.4 million in 2020 to $44.3 million in 2021[4] - Gross profit margin improved from 59.6% in 2020 to 61.5% in 2021[8] - Adjusted EBITDA loss decreased from $(11.0) million in 2020 to $(8.7) million in 2021[6] - Operating expense ratio decreased from 104.4% in FY 2020 to 96.3% in FY 2021[9] Q4 2021 Results - Revenues increased by 40.2% from $7.7 million in Q4 2020 to $10.8 million in Q4 2021[12] - Gross profit increased by 31.5% from $4.9 million in Q4 2020 to $6.5 million in Q4 2021[12] - Adjusted EBITDA loss increased by 78.7% from $(2.2) million in Q4 2020 to $(4.0) million in Q4 2021[12] Cash Flow and Debt - Cash used in operations improved from $(16.0) million to $(10.0) million[10] - Ending cash increased by $3.8 million to $19.6 million[10] - Net debt increased by $1.7 million[10] Merger Highlights - The merger creates a combined revenue of +$300 million growing at a +20% CAGR over the past 4 years[11]